Report / New China Pharma Report October 2019 Out Now
Download our latest pharma country report on China here 2019 is a landmark year for China, marking not only…
China
Biotech / 5 Biotechs to Watch China October 2019
China-born entrepreneurs are returning to their homeland to find an industry filled with incentives in place for innovation, independent of generics. Here, we highlight five unique biotechs looking to serve…
Rare Diseases / A New Paradigm in China
Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the…
Company Profile / Servier China, 40 Years of Commitment
2009 marks 40 years of China’s liberalization and opening up under then-Premier Deng Xiaoping. Servier China also…
Pharma Faces
Li Bangliang
Chairman | Huadong Medicine
Huijuan Zhong
Chairperson & Founder | Hansoh Pharma
Zheng Jianxiong
President | Guangzhou Pharmaceutical Holdings
In Conversation
Mike Braun – Partner, Deloitte China
Mike Braun, partner at Deloitte China, shares his perspectives on the recent China reforms, the strong presence of Deloitte within China as a consulting firm with a DNA in professional services, the importance of the healthcare and life sciences industry to their business here, and their commitment to delivering comprehensive solutions to their clients. In the past few years,…
Top 10 Chinese Pharma Companies 2018
These ten Chinese pharma companies ranked by 2018 revenues, each brought in more than a billion US dollars.…
Related Report
Regulatory / Chinese Pharma Legal Update: September 2019
Fangda Partners’ Josh Shin gives an overview of recent regulatory upgrades affecting the Chinese…
Policy / How Big Pharma is Adapting to China’s Rapid Regulatory Changes
China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma…
Career / China's Pharma Talent Story
Given the undeniably challenging and dynamic China market, most industry stakeholders would agree that the…
China’s Vaccine Crisis
One of China’s biggest vaccine manufacturers was found to have falsified rabies vaccine records causing…
The Ideal Pharma Country Manager: China (Cornerstone International)
What do executive recruitment firms look for when hiring country managers for multinational pharma companies in…
Venture Capital and China’s Life Sciences: New Territories
Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy…
China / Bringing Together Innovation & Investment in Suzhou: CBIIC 2019
On 21 September 2019, the China Pharmaceutical International Innovation and Research Development Association…
‘Made in China’ – a Badge of Dishonour?
One of China’s biggest vaccine manufacturers was found to have falsified rabies vaccine records causing…
US-China Tensions Heating Up in the Life Sciences
Eurasia Group’s Aditya Bhattacharji looks at the potentially damaging fallout of the ongoing US-China trade war…
IP in China: From Imitation to Innovation
The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing…
Talent / The Sea Turtles: China's Top Pharma Talent Comes Home
The meteoric growth of the pharmaceutical industry in China in recent years has seen a host of top Chinese talent…
Pharma CEO Pair Become China’s Richest Couple
Following Hansoh’s recent IPO in Hong Kong, CEO Zhong Huijuan and husband Sun Piaoyang, CEO of Jiangsu…
China’s Greater Bay Area and Hong Kong Life Sciences
One of the more eye-catching and ambitious initiatives to come out of last March’s National People’s Congress,…
Biotech / 5 Biotechs to Watch China October 2019
China-born entrepreneurs are returning to their homeland to find an industry filled with incentives in place for…
China to Establish National Medical Ethics Committee Post-CRISPR Controversy
China is planning to establish a new national medical ethics committee in the wake of the “CRISPR babies”…
The Ideal Pharma Country Manager: China (Ardent Search)
The lowdown on what it takes to be a country manager of a multinational pharma company in some of the world’s…
Chengdu: The First Steps Towards Mutual Insurance In China
Better known for its panda sanctuary and spicy local cuisine, Chengdu could be the first Chinese city to offer…
5 Biotechs to Watch in China
Even though China’s pharmaceutical sector remains largely generics-based, the Middle Kingdom’s biotechnology…
Bio 2019 / Hong Kong Biotech IPOs Soaring in Line with China Pharma Market
With Hong Kong now established as the world’s second largest funding hub for biotech, at this week’s BIO 2019…
China’s Greater Bay Area: Spearheading Innovation
Guangdong province and neighbouring Hong Kong have long been fundamental to China’s metamorphosis into an…
Pharma Faces / Felix Gutsche, Boehringer Ingelheim China
2019 saw Boehringer Ingelheim (BI) veteran Felix Gutsche take up his first country manager role – of a top-three…
Company Profile / Servier China, 40 Years of Commitment
2009 marks 40 years of China’s liberalization and opening up under then-Premier Deng Xiaoping. Servier China also…
China: Increased Regulation Leads to Flu Vaccine Shortages
Following China’s vaccine scandal earlier this year, the country’s drug administration has considerably…
4 Key Trends at the Country Manager Level in China
Multinational pharma companies have been setting up shop in China ever since Novartis launched its Chinese…
Dermo-Cosmetics / Allergan: Doubling Down in China’s New Capital of Medical Aesthetics
Global medical aesthetics market leader Allergan is investing heavily in the Chinese city of Chengdu and has…
4+7: China’s New Volume-Based Purchasing Policy
In late 2018 China adopted a novel procurement scheme with the aim of dramatically cutting the amount being paid…
Biotech / 5 More Biotechs to Watch in China
Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making…
China: A New Biopharma Model Emerging
Professor Richard Barker, founder of New Medicine Partners reflects on China’s very different approach to…
China to Cut Taxes for Rare Disease Drugs
It has been announced by China’s State Council that as of March 1st 2019, the government will reduce the VAT…